ITEL
23.2.2024 18:36:34 CET | Business Wire | Press release
itel, the global leading smart life brand committed to providing affordable and good quality consumer electronic products, is poised to redefine its visual identity with the spectacular launch of its new logo at the iconic Great Pyramids of Giza in Egypt on February 22. This momentous occasion will not only mark a significant evolution in itel’s brand image but also serve as a platform to engage and celebrate with esteemed partners and customers worldwide, especially customers from the Middle East and North Africa region.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240222762808/en/
itel successfully launched its 2024 brand launch event at Egyptian Pyramids (Photo: Business Wire)
The unveiling ceremony at the Egyptian Pyramids signifies itel’s commitment not only to technological innovation but also to creating a memorable and immersive experience for attendees. The event will kick off with a breathtaking display of opening fireworks, setting the stage for an evening of celebration and anticipation, followed by an inspiring opening speech. Subsequently, attendees will be treated to a captivating logo Show, where the new logo design will be unveiled with a profound interpretation of its significance to itel’s brand identity.
As part of the event, itel will officially launch the highly anticipated itel P55 series smartphones, including P55+, P55, and P55 5G. These smartphones boast three major technological upgrades: 45W PowerCharge technology with three-gear smart charging; iBoost game space, optimizing the gaming experience. And itel’s first 5G smartphone P55 5G, providing a fast browsing experience for entry-level 5G network customers in emerging markets.
In addition to the smartphone launch, itel also introduced a range of smart life accessories, including smartwatch E1, with features such as blood oxygen monitoring, heartbeat tracking, and health management, intelligent earbuds BudsAce, featuring noise reduction and superior sound quality, and other reliable and affordable home appliances and innovative kids electronics, as part of its commitment to a holistic smart lifestyle.
“We are thrilled to welcome esteemed partners, prominent media representatives, and KOLs to our grand unveiling at the Egyptian Pyramids,” said Steven Yang, North Africa Regional Director of itel. “This event is not merely a product launch. It's an opportunity for friendly exchanges, fostering close customer relationships, promoting future collaborations, and maintaining long-term, close contact with our valued partners. We aim to demonstrate the unparalleled service level of itel’s international brand and showcase our commitment to creating lasting connections in this vibrant and dynamic region.”
The gathering at the Egyptian Pyramids, one of the Eight Wonders of the World, symbolizes itel's transition into a daring new era characterized by innovation and enduring style. Be prepared to witness the unfolding of a new chapter in the brand’s legacy, marking its unwavering commitment to delivering not just technology but a refined and immersive experience.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240222762808/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release
Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around
Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release
Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5
HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate
Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro
Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom